Table 3.
OR for association of patient characteristics with fall(s)
| Characteristics | 1+ Falls in the past 12 months |
|||
|---|---|---|---|---|
| Unadjusted OR (95% CI) | P-value | Adjusted OR (95% CI)a | P-value | |
| Age, years | 1.02 (1.01, 1.04) | <0.001 | 1.02 (1.01, 1.04) | 0.01 |
| Gender | ||||
| Male (reference) | 1.00 | 1.00 | ||
| Female | 1.40 (1.01, 1.93) | 0.04 | 1.35 (0.92, 1.98) | 0.12 |
| Race, % | ||||
| White (reference) | 1.00 | 1.00 | ||
| Black | 0.71 (0.49, 1.04) | 0.08 | 0.85 (0.46, 1.56) | 0.60 |
| Other | 0.77 (0.46, 1.31) | 0.34 | 0.77 (0.42, 1.41) | 0.39 |
| Vintage | 0.97 (0.94, 1.00) | 0.09 | 1.00 (0.96, 1.04) | 0.90 |
| Diabetes | 1.22 (0.89, 1.68) | 0.23 | 0.82 (0.54, 1.25) | 0.34 |
| CHF | 1.63 (1.16, 2.30) | 0.005 | 1.44 (0.96, 2.16) | 0.08 |
| CAD/MI | 1.18 (0.83, 1.68) | 0.36 | 0.80 (0.50, 1.27) | 0.34 |
| CVA/TIA | 1.51 (0.92, 2.48) | 0.10 | 1.19 (0.68, 2.10) | 0.55 |
| PVD | 1.70 (1.03, 2.82) | 0.04 | 1.39 (0.75, 2.57) | 0.30 |
| Other cardiac diseases | 1.34 (0.94, 1.91) | 0.11 | 0.77 (0.48, 1.24) | 0.29 |
| COPD | 2.23 (1.30, 3.81) | 0.003 | 1.20 (0.63, 2.28) | 0.59 |
| KDQOL-CF score | 0.98 (0.97, 0.99) | <0.001 | 0.99 (0.97, 0.997) | 0.01 |
| # Of prescribed medications | 1.08 (1.05, 1.12) | <0.001 | 1.03 (0.98, 1.08) | 0.22 |
| Total balance tests score | 0.84 (0.76, 0.93) | <0.001 | 1.06 (0.91, 1.23) | 0.45 |
| Frailty classification | ||||
| Non-frail (reference) | 1.00 | 1.00 | ||
| Prefrail | 2.01 (1.33, 3.04) | 0.001 | 1.57 (0.99, 2.50) | 0.06 |
| Frail | 4.82 (2.85, 8.17) | <0.001 | 2.39 (1.22, 4.71) | 0.01 |
| CES-D score/antidepressant(s) | ||||
| CES-D <18/no antidepressant(s) (reference) | ||||
| CES-D 18+/antidepressant(s) | 4.03 (2.12, 7.66) | <0.001 | 2.19 (0.99, 4.84) | 0.05 |
| CES-D 18+/no antidepressant(s) | 2.56 (1.71, 3.84) | <0.001 | 2.02 (1.26, 3.26) | 0.004 |
| CES-D <18/antidepressant(s) | 2.25 (1.33, 3.80) | 0.003 | 1.42 (0.77, 2.61) | 0.27 |
| BMI | ||||
| <18.5 | 2.24 (0.80, 6.25) | 0.12 | 1.34 (0.39, 4.57) | 0.64 |
| [18.5, 25) | 1.00 | 1.00 | ||
| [25, 30) | 1.07 (0.71, 1.62) | 0.73 | 1.05 (0.66, 1.67) | 0.81 |
| ≥30 | 1.31 (0.89, 1.92) | 0.17 | 1.32 (0.84, 2.08) | 0.23 |
| Serum albumin | 0.42 (0.28, 0.65) | <0.0001 | 0.83 (0.49, 1.40) | 0.48 |
BMI, body mass index; CAD, coronary artery disease; CES-D, Center for Epidemiologic Studies-Depression; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; HD, hemodialysis; KDQOL-CF, Kidney Disease Quality of Life-Cognitive Function; MI, myocardial infarction; other antidepressant class, atypical antidepressant or tricyclic antidepressant; other cardiac disease, cardiac dysrhythmia, atrial fibrillation, tachycardia, pericarditis, cardiac arrest; PVD, peripheral vascular disease; SSRI, selective serotonin reuptake inhibitor; TIA, transient ischemic attack; Total balance tests score, sum (range 0–4) over three tests from the Short Physical Performance Battery.
an = 720 participants with information for all covariates; analysis stratified by dialysis units.